Glycine Cognition Randomized Trial: What the Evidence Says

Quick Answer

Glycine Cognition Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Specifically, these factors encompass social isolation, stigma, substance use, poor dietary habits, and reduced prospects of finding a partner. [Yamada Yuji (2026); evidence level 1]
• Three groups of two investigators (RK, HO, SI, TH, TU, and YY) independently performed a quality assessment using the Cochrane Risk of Bias 2 Tool. [Yamada Yuji (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For glycine cognition randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Yamada Yuji (2026). Pharmacological interventions for social cognitive impairments in schizophrenia: A systematic review and network meta-analysis of randomized controlled trials. DOI: 10.1192/j.eurpsy.2026.10159. PMCID: PMC13122521. PMID: 41684115. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13122521/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.